BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8888319)

  • 1. Experts' agreement on the relative effectiveness of 29 smoking reduction strategies.
    Paul CL; Sanson-Fisher RW
    Prev Med; 1996; 25(5):517-26. PubMed ID: 8888319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effective primary care-based strategies to improve smoking cessation: more value for money.
    Salize HJ; Merkel S; Reinhard I; Twardella D; Mann K; Brenner H
    Arch Intern Med; 2009 Feb; 169(3):230-5; discussion 235-6. PubMed ID: 19204212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct telemarketing of smoking cessation interventions: will smokers take the call?
    Paul CL; Wiggers J; Daly JB; Green S; Walsh RA; Knight J; Girgis A
    Addiction; 2004 Jul; 99(7):907-13. PubMed ID: 15200586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Smoking reduction and temporary abstinence: new approaches for smoking cessation].
    Le Houezec J; Säwe U
    J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking cessation in a blue-collar population: results from an evidence-based pilot program.
    Ringen K; Anderson N; McAfee T; Zbikowski SM; Fales D
    Am J Ind Med; 2002 Nov; 42(5):367-77. PubMed ID: 12382249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing smoking prevalence in Australian prisons: a review of policy options.
    Awofeso N
    Appl Health Econ Health Policy; 2002; 1(4):211-8. PubMed ID: 14619250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing the burden of smoking world-wide: effectiveness of interventions and their coverage.
    Jha P; Chaloupka FJ; Corrao M; Jacob B
    Drug Alcohol Rev; 2006 Nov; 25(6):597-609. PubMed ID: 17132576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and cost-effectiveness of a minimal intervention to prevent smoking relapse: dismantling the effects of amount of content versus contact.
    Brandon TH; Meade CD; Herzog TA; Chirikos TN; Webb MS; Cantor AB
    J Consult Clin Psychol; 2004 Oct; 72(5):797-808. PubMed ID: 15482038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reflections on 30+ years of smoking cessation research: from the individual to the world.
    Lando HA
    Drug Alcohol Rev; 2006 Jan; 25(1):5-14. PubMed ID: 16492572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tobacco prevention in children and cessation in family members.
    Tingen MS; Waller JL; Smith TM; Baker RR; Reyes J; Treiber FA
    J Am Acad Nurse Pract; 2006 Apr; 18(4):169-79. PubMed ID: 16573730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of the Danish smoking cessation interventions: subgroup analysis based on the Danish Smoking Cessation Database.
    Olsen KR; Bilde L; Juhl HH; Kjaer NT; Mosbech H; Evald T; Rasmussen M; Hiladakis H
    Eur J Health Econ; 2006 Dec; 7(4):255-64. PubMed ID: 16816946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of a family physician delivered smoking cessation program.
    Buck DJ; Richmond RL; Mendelsohn CP
    Prev Med; 2000 Dec; 31(6):641-8. PubMed ID: 11133329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost effectiveness of pharmacotherapies for smoking cessation: necessary but not sufficient?
    Shanahan M; Doran C; Gates J; Shakeshaft A; Mattick RP
    Appl Health Econ Health Policy; 2003; 2(2):76-8. PubMed ID: 14619277
    [No Abstract]   [Full Text] [Related]  

  • 14. The future of tobacco-control research.
    Morgan GD; Backinger CL; Leischow SJ
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1077-80. PubMed ID: 17548666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating smoking cessation into mental health care for post-traumatic stress disorder.
    McFall M; Saxon AJ; Thaneemit-Chen S; Smith MW; Joseph AM; Carmody TP; Beckham JC; Malte CA; Vertrees JE; Boardman KD; Lavori PW
    Clin Trials; 2007; 4(2):178-89. PubMed ID: 17456521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of varenicline for smoking cessation.
    Keiding H
    Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):215-21. PubMed ID: 19527093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What's needed for personalized therapy in smoking cessation.
    Epstein RS
    Clin Pharmacol Ther; 2008 Sep; 84(3):309-10. PubMed ID: 18714320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobacco control curricula content in baccalaureate nursing programs in four Asian nations.
    Sarna L; Danao LL; Chan SS; Shin SR; Baldago LA; Endo E; Minegishi H; Wewers ME
    Nurs Outlook; 2006; 54(6):334-44. PubMed ID: 17142152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of tobacco cessation intervention programs.
    Sinha DN; Dobe M
    Indian J Public Health; 2004; 48(3):138-43. PubMed ID: 15709601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applying an equity lens to tobacco-control policies and their uptake in six Western-European countries.
    Giskes K; Kunst AE; Ariza C; Benach J; Borrell C; Helmert U; Judge K; Lahelma E; Moussa K; Ostergren PO; Patja K; Platt S; Prättälä R; Willemsen MC; Mackenbach JP
    J Public Health Policy; 2007 Jul; 28(2):261-80. PubMed ID: 17585326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.